Literature DB >> 20232155

Molecular analysis of Candida glabrata clinical isolates.

Norbert Berila1, Julius Subik.   

Abstract

Candida glabrata is an important human pathogen, and an understanding of the genetic relatedness of its clinical isolates is essential for the prevention and control of fungal infections. In this study, we determined the relatedness of 38 Candida glabrata clinical isolates originating from two teaching hospitals in Slovakia. The 14 different genotypes were found by using microsatellite marker analysis (RPM2, MTI and Cg6) and DNA sequencing for analysis of the entire ERG11 gene. Subsequent sequencing of amplified DNA fragments of the PDR1, NMT1, TRP1 and URA3 loci in ten selected clinical isolates revealed identical DNA sequence profiles in five of them. They displayed the same microsatellite marker sizes and contained the same H576Y amino acid substitution recently described in the Pdr1p multidrug resistance transcription factor responsible for azole resistance. These results demonstrate the genetic diversity of C. glabrata clinical isolates in our hospitals and indicate a common clonal origin of some drug resistant ones.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232155     DOI: 10.1007/s11046-010-9298-1

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  19 in total

Review 1.  Amplification-based nucleic acid scanning techniques to assess genetic polymorphism in Candida.

Authors:  R S Dassanayake; L P Samaranayake
Journal:  Crit Rev Microbiol       Date:  2003       Impact factor: 7.624

2.  Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.

Authors:  M A Pfaller; S A Messer; R J Hollis; R N Jones; G V Doern; M E Brandt; R A Hajjeh
Journal:  Diagn Microbiol Infect Dis       Date:  1999-04       Impact factor: 2.803

3.  Microsatellite marker analysis as a typing system for Candida glabrata.

Authors:  F Foulet; N Nicolas; O Eloy; F Botterel; J-C Gantier; J-M Costa; S Bretagne
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.

Authors:  J D Sobel; W Chaim
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

Review 5.  Biology of the pathogenic yeast Candida glabrata.

Authors:  A Bialková; J Subík
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

6.  Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.

Authors:  Jack D Sobel; Harold C Wiesenfeld; Mark Martens; Penny Danna; Thomas M Hooton; Anne Rompalo; Malcolm Sperling; Charles Livengood; Benson Horowitz; James Von Thron; Libby Edwards; Helene Panzer; Teng-Chiao Chu
Journal:  N Engl J Med       Date:  2004-08-26       Impact factor: 91.245

7.  Multilocus sequence typing of Candida glabrata reveals geographically enriched clades.

Authors:  Andrew R Dodgson; Claude Pujol; David W Denning; David R Soll; Andrew J Fox
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.

Authors:  Monika Sojakova; Denisa Liptajova; Miroslav Borovsky; Julius Subik
Journal:  Mycopathologia       Date:  2004-02       Impact factor: 2.574

9.  Multiple-locus variable-number tandem-repeat analysis for rapid typing of Candida glabrata.

Authors:  Frédéric Grenouillet; Laurence Millon; Jean-Mathieu Bart; Sandrine Roussel; Isabelle Biot; Emeline Didier; Anne-Sophie Ong; Renaud Piarroux
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

10.  Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia.

Authors:  Jong Hee Shin; Myung Jong Chae; Jeong Won Song; Sook-In Jung; Duck Cho; Seung Jung Kee; Soo Hyun Kim; Myung Geun Shin; Soon Pal Suh; Dong Wook Ryang
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

View more
  10 in total

1.  Oxidative stress response and virulence factors in Candida glabrata clinical isolates.

Authors:  N Berila; P Hyroššová; J Subík
Journal:  Folia Microbiol (Praha)       Date:  2011-03-18       Impact factor: 2.099

2.  Evaluation of Polymorphic Locus Sequence Typing for Candida glabrata Epidemiology.

Authors:  Santosh Katiyar; Eric Shiffrin; Celeste Shelton; Kelley Healey; John-Paul Vermitsky; Tom Edlind
Journal:  J Clin Microbiol       Date:  2016-02-03       Impact factor: 5.948

3.  Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata.

Authors:  Sélène Ferrari; Maurizio Sanguinetti; Riccardo Torelli; Brunella Posteraro; Dominique Sanglard
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

4.  Heteroresistance to Fluconazole Is a Continuously Distributed Phenotype among Candida glabrata Clinical Strains Associated with In Vivo Persistence.

Authors:  Ronen Ben-Ami; Offer Zimmerman; Talya Finn; Sharon Amit; Anna Novikov; Noa Wertheimer; Mor Lurie-Weinberger; Judith Berman
Journal:  MBio       Date:  2016-08-02       Impact factor: 7.867

5.  Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species.

Authors:  Danielly Beraldo dos Santos Silva; Luana Mireli Carbonera Rodrigues; Adriana Araújo de Almeida; Kelly Mari Pires de Oliveira; Alexéia Barufatti Grisolia
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-03-15       Impact factor: 2.743

6.  Tetrahydrocarbazoles are a novel class of potent P-type ATPase inhibitors with antifungal activity.

Authors:  Maike Bublitz; Lasse Kjellerup; Karen O'Hanlon Cohrt; Sandra Gordon; Anne Louise Mortensen; Johannes D Clausen; Thomas David Pallin; John Bondo Hansen; Anja Thoe Fuglsang; William Dalby-Brown; Anne-Marie L Winther
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

7.  Novel Zinc-Attenuating Compounds as Potent Broad-Spectrum Antifungal Agents with In Vitro and In Vivo Efficacy.

Authors:  Karen A O'Hanlon Cohrt; Laura Marín; Lasse Kjellerup; Johannes D Clausen; William Dalby-Brown; José Antonio Calera; Anne-Marie Lund Winther
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

8.  Overexpression of aldo-keto-reductase in azole-resistant clinical isolates of Candida glabrata determined by cDNA-AFLP.

Authors:  Shirin Farahyar; Farideh Zaini; Parivash Kordbacheh; Sassan Rezaie; Mahin Safara; Reza Raoofian; Mansour Heidari
Journal:  Daru       Date:  2013-01-02       Impact factor: 3.117

9.  Sorbic acid stress activates the Candida glabrata high osmolarity glycerol MAP kinase pathway.

Authors:  Zeljkica Jandric; Christa Gregori; Eva Klopf; Martin Radolf; Christoph Schüller
Journal:  Front Microbiol       Date:  2013-11-26       Impact factor: 5.640

10.  Elucidation of antimicrobial activity and mechanism of action by N-substituted carbazole derivatives.

Authors:  Johannes D Clausen; Lasse Kjellerup; Karen O'Hanlon Cohrt; John Bondo Hansen; William Dalby-Brown; Anne-Marie L Winther
Journal:  Bioorg Med Chem Lett       Date:  2017-09-01       Impact factor: 2.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.